sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Middle East and Africa Cardiometabolic Diseases Market...

中东和非洲心血管代谢疾病市场预测至 2028 年 - COVID-19 影响和按类型（心血管疾病 (CVD)、2 型糖尿病、高血压和肥胖）、治疗（ACE 抑制剂、利尿剂、格华止等）的区域分析，剂量（片剂和注射剂）、给药途径（口服和静脉注射）、最终用户（医院、诊所和家庭护理机构）和分销渠道（医院药房、零售药房和在线药房）

TIPRE00026138 | Pages: 154 | Pharmaceuticals | Dec 2021 | Type: Regional | Status: Published

市场介绍

心脏代谢疾病的特点是一组异常和症状，这些异常和症状会引起个人患心血管疾病的风险。高血压、肥胖、胰岛素抵抗、血脂异常、胆固醇水平 (LDL) 不良和葡萄糖耐量是其中一些症状。患有心脏代谢综合征的人容易患上其他几种危及生命的疾病，例如 2 型糖尿病、中风、冠状动脉疾病 (CAD)、心血管疾病 (CVD) 等。

此外，心脏代谢疾病的日益流行预计将推动预测期内的市场增长。然而，中低收入国家 (LMIC) 对心血管疾病的诊断不足限制了中东和非洲心脏代谢疾病市场的增长。

疫情增加了对心血管疾病的需求可用于家庭护理环境的医疗设备。该地区入住重症监护病房 (ICU) 的患者数量不断增加。越来越多的药物给压力重重的医疗保健系统带来了多重诊断和治疗挑战，导致医疗设备和药品的增加。此外，慢性病病例数量不断增加，导致抗击病毒药物的使用增加。在 COVID-19 大流行期间，人们一直担心某些降压药物的潜力，例如血管紧张素转换酶抑制剂 (ACEi) 和血管紧张素转换阻滞剂 (ARB)。目前的严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 使用膜结合的血管紧张素转换酶 2 (ACE2) 受体来促进进入宿主细胞。此次大流行增强了该地区心脏代谢疾病市场各药品制造商的业务运营。

市场概况和动态

中东和非洲心脏代谢疾病市场预计将从 2021 年的 43.009 亿美元增至 2028 年的 50.085 亿美元；预计 2021 年至 2028 年复合年增长率为 2.2%。基于 CMD 的候选药物管道正在扩大用于广泛的治疗应用，包括高血压、糖尿病和炎症性疾病。许多大大小小的制药公司都参与了多种小分子药物的开发。例如，阿斯利康在早期至晚期心血管、肾脏和代谢 (CVRM) 领域拥有超过 25 种疗法和疗法组合。基于先进技术，目前正在推出多种治疗 CMD 的产品。此外，对 CMD 相关研究的投资不断增加，正在显着推动心脏代谢疾病市场的发展。所有这些投资都对中东和非洲心脏代谢疾病市场的增长产生了积极的影响。

关键细分市场

从类型来看，心血管疾病细分市场在2020年中东和非洲心脏代谢疾病市场中占据最大份额。从治疗角度来看，ACE抑制剂细分市场占据了最大份额。 2020年中东和非洲心脏代谢疾病市场中，片剂占据最大份额。从剂量来看，2020年中东和非洲心脏代谢疾病市场中，片剂占据最大份额。从给药途径来看，口服2020年，医院细分市场在中东和非洲心脏代谢疾病市场中占据最大份额。就最终用户而言，医院细分市场在2020年中东和非洲心脏代谢疾病市场中占据最大份额。此外，根据分销渠道医院药房细分市场在2020年占据最大市场份额。

主要来源和上市公司

准备本中东和非洲心脏代谢疾病市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括拜耳公司、诺华公司、勃林格殷格翰国际有限公司、诺和诺德公司和阿斯利康公司。

购买报告的理由

  • 了解中东和非洲心脏代谢疾病市场规划并识别可能保证丰厚回报的细分市场
  • 了解不断变化的市场格局并在竞争中保持领先地位
  • 通过确定最有可能销售前景的细分市场，有效规划中东和非洲心脏代谢疾病市场的并购和合作伙伴关系
  • 打造知识型业务通过对各个细分市场表现的敏锐和综合分析来做出决策
  • 根据各个细分市场获得中东和非洲心脏代谢疾病市场的市场收入预测2021-2028年期间

中东和非洲心血管代谢疾病市场细分

< p>按类型

  • 心血管疾病（CVD）
  • 2型糖尿病
  • 高血压
  • 肥胖

< span>治疗

  • ACE抑制剂
  • 利尿剂
  • 格华止
  • 其他

按剂量

  • 片剂
  • 注射剂
< p>按给药途径

  • 口服
  • 静脉注射

最终用户

  • 医院
  • 诊所
  • 家庭护理设置

通过分销渠道

  • 医院药房
  • 零售药房
  • 网上药店

按国家/地区

  • 中东和非洲
  • 阿联酋
  • 沙特阿拉伯
  • 南非
  • 中东和非洲其他地区

提及的公司

  • 拜耳公司                     
  • 诺华公司             ;     
  • 勃林格殷格翰国际有限公司
  • 诺和诺德公司       
  • 阿斯利康                

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.7        Middle East and Africa Cardiometabolic Diseases market – By Country

2.           Middle East and Africa Cardiometabolic Diseases Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East and Africa Cardiometabolic Diseases Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Expert Opinions

5.           Middle East and Africa Cardiometabolic Diseases Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cardiometabolic Diseases

5.1.2        Innovation in Cardiometabolic Diseases Therapeutics

5.2         Market Restraints

5.2.1        Underdiagnosis of CVDs in Low- and Middle-Income Countries (LMICs)

5.3         Market Opportunities

5.3.1        Technological Advancements in CMD Diagnosis

5.4         Future Trends

5.4.1        Personalized Treatment for CMDs

5.5         Impact Analysis

6.           Middle East and Africa Cardiometabolic Diseases Market – Regional Analysis

6.1         Middle East and Africa Cardiometabolic Diseases Market Revenue Forecast And Analysis

7.           Middle East and Africa Cardiometabolic Diseases Market Analysis – By Type

7.1         Overview

7.2         Cardiometabolic Diseases Market Revenue Share, by Type (2020 and 2028)

7.3         Cardiovascular Disease (CVD)

7.3.1        Overview

7.3.2        Cardiovascular Disease (CVD): Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

7.4         Hypertension

7.4.1        Overview

7.4.2        Hypertension: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

7.5         Type 2 Diabetes

7.5.1        Overview

7.5.2        Type 2 Diabetes: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

7.6         Obesity

7.6.1        Overview

7.6.2        Obesity: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.           Middle East and Africa Cardiometabolic Diseases Market Analysis – By Treatment

8.1         Overview

8.2         Cardiometabolic Diseases Market Revenue Share, by Treatment (2020 and 2028)

8.3         ACE inhibitors

8.3.1        Overview

8.3.2        ACE: Cardiometabolic Diseases Inhibitors Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Diuretics

8.4.1        Overview

8.4.2        Diuretics: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Glucophage

8.5.1        Overview

8.5.2        Glucophage: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Others

8.6.1        Overview

8.6.2        Others: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

9.           Middle East and Africa Cardiometabolic Diseases Market Analysis – By Dosage

9.1         Overview

9.2         Cardiometabolic Diseases Market Revenue Share, by Dosage (2020 and 2028)

9.3         Tablet

9.3.1        Overview

9.3.2        Tablet: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Injection

9.4.1        Overview

9.4.2        Injection: Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Mn)

10.        Middle East and Africa Cardiometabolic Diseases Market Analysis – By Route of Administration

10.1      Overview

10.2      Cardiometabolic Diseases Market Share by Route of Administration 2021 & 2028 (%)

10.3      Oral

10.3.1     Overview

10.3.2     Oral Market Revenue and Forecast to 2028 (US$ Mn)

10.4      Intravenous

10.4.1     Overview

10.4.2     Intravenous Market Revenue and Forecast to 2028 (US$ Mn)

11.        Middle East and Africa Cardiometabolic Diseases Market Analysis – By End User

11.1      Overview

11.2      Cardiometabolic Diseases Market Share by End Users 2020 & 2028 (%)

11.3      Clinic

11.3.1     Overview

11.3.2     Clinic Market Revenue and Forecast to 2028 (US$ Mn)

11.4      Hospital

11.4.1     Overview

11.4.2     Hospital Market Revenue and Forecast to 2028 (US$ Mn)

11.5      Homecare Settings

11.5.1     Overview

11.5.2     Homecare Settings Market Revenue and Forecast to 2028 (US$ Mn)

12.        Middle East and Africa Cardiometabolic Diseases Market Analysis – By Distribution Channel

12.1      Overview

12.2      Cardiometabolic Diseases Market Share by Distribution Channel 2020 & 2028 (%)

12.3      Hospital Pharmacy

12.3.1     Overview

12.3.2     Hospital Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

12.4      Retail Pharmacy

12.4.1     Overview

12.4.2     Retail Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

12.5      Online Pharmacy

12.5.1     Overview

12.5.2     Online Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)

13.        Middle East and Africa Cardiometabolic Diseases Market – Geographic Analysis

13.1      Middle East and Africa: Cardiometabolic Diseases Market

13.1.1     Overview

13.1.2     Middle East & Africa: Cardiometabolic Diseases Market - Revenue and Forecast to 2028 (US$ Million)

13.1.3     Middle East & Africa: Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

13.1.4     Middle East & Africa: Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

13.1.5     Middle East & Africa: Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

13.1.6     Middle East & Africa: Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

13.1.7     Middle East & Africa: Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

13.1.8     Middle East & Africa: Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

13.1.9     Middle East and Africa: Cardiometabolic Diseases Market, by Country, 2021 & 2028 (%)

13.1.9.1       Saudi Arabia: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (US$ Million)

13.1.9.1.1       Saudi Arabia: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (US$ Million)

13.1.10  Saudi Arabia: Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

13.1.11  Saudi Arabia: Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

13.1.12  Saudi Arabia: Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

13.1.13  Saudi Arabia: Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

13.1.14  Saudi Arabia: Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

13.1.15  Saudi Arabia: Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

13.1.15.1    UAE: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (US$ Million)

13.1.15.1.1    UAE: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (US$ Million)

13.1.15.1.2    UAE: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (US$ Million)

13.1.16  UAE: Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

13.1.17  UAE: Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

13.1.18  UAE: Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

13.1.19  UAE: Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

13.1.20  UAE: Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

13.1.21  UAE: Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

13.1.21.1    South Africa: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (US$ Million)

13.1.21.1.1    South Africa: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (US$ Million)

13.1.22  South Africa: Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

13.1.23  South Africa: Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

13.1.24  South Africa: Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

13.1.25  South Africa: Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

13.1.26  South Africa: Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

13.1.27  South Africa: Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

13.1.27.1    Rest of Middle East and Africa: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (US$ Million)

13.1.27.1.1    Rest of Middle East and Africa: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (US$ Million)

13.1.28  Rest of Middle East and Africa: Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

13.1.29  Rest of Middle East and Africa: Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

13.1.30  Rest of Middle East and Africa: Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

13.1.31  Rest of Middle East and Africa: Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

13.1.32  Rest of Middle East and Africa: Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

13.1.33  Rest of Middle East and Africa: Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

14.        Impact of COVID-19 Pandemic on Middle East and Africa Cardiometabolic Diseases Market

14.1      Middle East and Africa: Impact Assessment of COVID-19 Pandemic

15.        Middle East and Africa Cardiometabolic Diseases Market – Industry Landscape

15.1      Overview

15.2      Growth Strategies in the Cardiometabolic Diseases Market (%)

15.3      Organic Developments

15.3.1     Overview

15.4      Inorganic Developments

15.4.1     Overview

16.        Company Profiles

16.1      Bayer AG

16.1.1     Key Facts

16.1.2     Business Description

16.1.3     Products and Services

16.1.4     Financial Overview

16.1.5     SWOT Analysis

16.1.6     Key Developments

16.2      Novartis AG

16.2.1     Key Facts

16.2.2     Business Description

16.2.3     Products and Services

16.2.4     Financial Overview

16.2.5     SWOT Analysis

16.2.6     Key Developments

16.3      Boehringer Ingelheim International GmbH

16.3.1     Key Facts

16.3.2     Business Description

16.3.3     Products and Services

16.3.4     Financial Overview

16.3.5     SWOT Analysis

16.3.6     Key Developments

16.4      Novo Nordisk A/S

16.4.1     Key Facts

16.4.2     Business Description

16.4.3     Products and Services

16.4.4     Financial Overview

16.4.5     SWOT Analysis

16.4.6     Key Developments

16.5      AstraZeneca

16.5.1     Key Facts

16.5.2     Business Description

16.5.3     Products and Services

16.5.4     Financial Overview

16.5.5     SWOT Analysis

16.5.6     Key Developments

17.        Appendix

17.1      About The Insight Partners

17.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Middle East & Africa Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 2.             Middle East & Africa Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 3.             Middle East & Africa Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 4.             Middle East & Africa Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 5.             Middle East & Africa Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

Table 6.             Middle East & Africa Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 7.             Saudi Arabia Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Saudi Arabia Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 9.             Saudi Arabia Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 10.          Saudi Arabia Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 11.          Saudi Arabia Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

Table 12.          Saudi Arabia Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 13.          UAE Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 14.          UAE Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 15.          UAE Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 16.          UAE Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 17.          UAE Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

Table 18.          UAE Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 19.          South Africa Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 20.          South Africa Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 21.          South Africa Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 22.          South Africa Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 23.          South Africa Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

Table 24.          South Africa Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 25.          Rest of Middle East and Africa Cardiometabolic Diseases Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 26.          Rest of Middle East and Africa Cardiometabolic Diseases Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 27.          Rest of Middle East and Africa Cardiometabolic Diseases Market, by Dosage – Revenue and Forecast to 2028 (USD Million)

Table 28.          Rest of Middle East and Africa Cardiometabolic Diseases Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 29.          Rest of Middle East and Africa Cardiometabolic Diseases Market, by End Users – Revenue and Forecast to 2028 (USD Million)

Table 30.          Rest of Middle East and Africa Cardiometabolic Diseases Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 31.          Organic Developments in the Cardiometabolic Diseases Market

Table 32.          Inorganic Developments in the Cardiometabolic Diseases Market

Table 33.          Glossary of Terms, Middle East and Africa Cardiometabolic Diseases Market

LIST OF FIGURES

Figure 1.           Middle East and Africa Cardiometabolic Diseases Market Segmentation

Figure 2.           Middle East and Africa Cardiometabolic Diseases Market Overview

Figure 3.           Cardiovascular Disease (CVD) Segment Held Largest Share of Type of Middle East and Africa Cardiometabolic Diseases Market

Figure 4.           Middle East and Africa Cardiometabolic Diseases Market – Leading Country Markets (US$ Million)

Figure 5.           Middle East and Africa Cardiometabolic Diseases Market, Industry Landscape

Figure 6.           Middle East and Africa PEST Analysis

Figure 7.           Middle East and Africa Cardiometabolic Diseases Market Impact Analysis of Drivers and Restraints

Figure 8.           Middle East and Africa Cardiometabolic Diseases Market – Revenue Forecast And Analysis – 2020- 2028

Figure 9.           Cardiometabolic Diseases Market Revenue Share, by Type (2020 and 2028)

Figure 10.        Cardiovascular Disease (CVD): Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        Hypertension: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        Type 2 Diabetes: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        Obesity: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        Cardiometabolic Diseases Market Revenue Share, by Treatment (2020 and 2028)

Figure 15.        ACE inhibitors: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16.        Diuretics: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        Glucophage: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        Others: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19.        Cardiometabolic Diseases Market Revenue Share, by Dosage (2020 and 2028)

Figure 20.        Tablet: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        Injection: Cardiometabolic Diseases Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.        Cardiometabolic Diseases Market Share by Route of Administration 2021 & 2028 (%)

Figure 23.        Oral Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24.        Intravenous Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25.        Cardiometabolic Diseases Market Share by End Users 2020 & 2028 (%)

Figure 26.        Clinic Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27.        Hospital Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28.        Homecare Settings Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29.        Cardiometabolic Diseases Market Share by Distribution Channel 2020 & 2028 (%)

Figure 30.        Hospital Pharmacy Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31.        Retail Pharmacy Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32.        Online Pharmacy Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 33.        Middle East and Africa: Cardiometabolic Diseases Market, by Key Country – Revenue (2021) (USD Million)

Figure 34.        Middle East & Africa Cardiometabolic Diseases Market Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Middle East and Africa: Cardiometabolic Diseases Market, by Country, 2021 & 2028 (%)

Figure 36.        Saudi Arabia: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37.        UAE: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        South Africa: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Rest of Middle East and Africa: Cardiometabolic Diseases Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40.        Impact of COVID-19 Pandemic on Middle East and Africa Cardiometabolic Diseases Market

Figure 41.        Growth Strategies in the Cardiometabolic Diseases Market (%)

 

  1. Bayer AG             
  2. Novartis AG          
  3. Boehringer Ingelheim International Gmbh
  4. Novo Nordisk A/S            
  5. AstraZeneca         
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East and Africa cardiometabolic diseases market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa cardiometabolic diseases market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S.. May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En.. May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription